title: Pharmacokinetics of hexamethylmelamine in intralipid following hepatic regional administration in rabbits.
abstract: Hexamethylmelamine (HMM) is a cytotoxic agent demonstrated to have broad antitumor activity. Poor solubility in aqueous media has precluded significant evaluation of parenteral administration of this drug. A formulation of HMM dissolved in Intralipid has demonstrated excellent tolerance following parenteral administration. The goal of this study was to evaluate the pharmacology of HMM in Intralipid following hepatic regional administration. The routes of administration were intraarterial via the hepatic artery with and without arterial occlusion, i.v. via the portal and jugular veins, and i.p. All animals received a total dose of 10 mg HMM/kg of body weight. Hepatic extraction of HMM was most evident via the portal vein (PV) route [AUC(PV)/AUC(i.v.) = 0.5; P less than 0.05]. Lower plasma levels and areas under the curve (AUCs) were observed for the hepatic artery and hepatic artery-stop flow groups when compared to i.v., but the difference was not significant. Administration i.p. yielded low plasma levels but a very long half-life (88 min). Hepatic tissue levels were highest in the group receiving HMM by the hepatic artery-stop flow route. We conclude that the HMM-Intralipid mixture is well tolerated, that HMM is extracted to a significant degree by the liver following PV administration, and that an i.p. installation of HMM-Intralipid results in prolonged plasma drug levels. This preclinical study supports further efforts at evaluation of parenteral administration of the HMM-intralipid mixture.
mesh_terms: D006585:Altretamine / Q000008:administration & dosage / Q000378:metabolism*; D000818:Animals; D005217:Fat Emulsions, Intravenous / Q000008:administration & dosage*; D005260:Female; D006207:Half-Life; D006499:Hepatic Artery; D007700:Kinetics; D008099:Liver / Q000378:metabolism*; D011169:Portal Vein; D011817:Rabbits; D014227:Triazines / Q000378:metabolism*
chemical_list: D005217:Fat Emulsions, Intravenous; D014227:Triazines; D006585:Altretamine